UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): ~~July~~ 19August 12, 2010

BIOSPHERE MEDICAL, INC.

(Exact Name of Registrant as Specified in Charter)

Delaware	000-23678	04-3216867
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)
(State or Other Jurisdiction of	(Commission File Number)	(IRS Employer
Incorporation)		Identification No.)

1050 Hingham Street
Rockland, Massachusetts		02370
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: (781) 681-7900

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

x o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 85.~~01.~~07 ~~Other~~Submission ~~Events~~of Matters to a Vote of Security Holders.

On ~~June~~August 1012, 2010, ~~certain of the members of the Board of Directors of~~ BioSphere Medical, Inc. (the “Company”) ~~were~~held ~~named as defendants in a putative class~~its ~~action~~2010 ~~complaint,~~Annual ~~captioned~~Meeting ~~Fessahaye v. Faleschini, et al., C.A. No. 5553-CC, filed in the Court~~ of ~~Chancery~~Stockholders of (the ~~State~~ of“Annual ~~Delaware~~Meeting”). ~~The~~In ~~action, purportedly~~light ~~brought on behalf~~ of ~~a class of~~ the Company’s ~~stockholders,~~previously ~~alleges that~~announced ~~certain~~execution of ~~the~~a ~~Company’s~~definitive ~~directors~~agreement ~~purportedly~~and ~~breached their fiduciary~~plan ~~duties~~of ~~in connection with the Company’s proposed~~ merger with Merit byMedical ~~failing to~~Systems, Inc. ~~maximize~~(“Merit”) ~~shareholder value~~ and ~~obtain the best financial and other~~Merit ~~terms~~BioAcquisition Co. ~~The~~, ~~complaint includes~~ a ~~request for~~wholly-owned ~~declaratory,~~subsidiary ~~injunctive~~of ~~and other equitable relief~~Merit, ~~including~~the toCompany ~~enjoin the~~determined ~~Company~~to ~~from~~further ~~consummating~~adjourn the ~~merger~~Annual ~~with Merit, in addition to fees and costs~~Meeting. OnAs ~~July 19,~~a ~~2010~~result, ~~plaintiff filed~~the ansole ~~amended~~order ~~complaint~~of business ~~adding~~at the ~~Company~~Annual asMeeting was a ~~defendant~~vote ~~and~~on ~~further alleging that~~ the ~~Company’s~~proposal ~~preliminary~~to ~~proxy~~adjourn ~~statement~~the ~~fails to provide~~Annual ~~material~~Meeting ~~information~~until ~~and~~September 10, ~~provides~~2010, ~~materially~~at ~~misleading~~11:00 ~~information~~Eastern ~~relating~~Daylight ~~to the~~Time, ~~proposed~~at ~~merger transaction. The~~the ~~Company~~offices ~~believes~~of ~~that~~WilmerHale, ~~the~~in ~~claims~~Boston, ~~are without merit and intends to defend the suit vigorously~~Massachusetts.

2The final number of votes cast for, against or abstaining from voting on that proposal are listed below:

~~SIGNATURE~~Proposal — To approve an adjournment of the 2010 Annual Meeting of Stockholders until September 10, 2010, at 11:00 a.m. Eastern Daylight Time at the offices of WilmerHale in Boston, Massachusetts.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Votes For		Votes Against		Abstain
15,822,666		0		5,322,679

Date: July 23, 2010	BIOSPHERE MEDICAL, INC.
	By:	/s/ Martin J. Joyce
		Martin J. Joyce
		Executive Vice President
		and Chief Financial Officer

3SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: August 16, 2010	BIOSPHERE MEDICAL, INC.


	By:	/s/ Martin J. Joyce
		Martin J. Joyce
		Executive Vice President and Chief Financial Officer

Filing Compare · BIOSPHERE MEDICAL INC